Alexza's Manufacturing Issues Delay FDA Approval Of Adasuve
Alexza Pharmaceuticals Inc.'s antipsychotic drug delivery system hit another snag Thursday when the U.S. Food and Drug Administration told the company it couldn't approve the device until the company resolved unspecified...To view the full article, register now.
Already a subscriber? Click here to view full article